Back to KROS
JANE STREET GROUP, LLC KROS Position History
Keros Therapeutics, Inc. • Healthcare
Quarters held
17
Latest value
$1.1M
Q3 2026
Peak value
$2.5M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $1.6M |
| Q3 2025 | $1.3M |
| Q3 2025 | $1M |
| Q3 2025 | $291K |
| Q3 2025 | $643K |
| Q4 2025 | $2.5M |
| Q4 2025 | $660K |
| Q4 2025 | $1K |
| Q4 2025 | $793K |
| Q1 2026 | $131K |
| Q1 2026 | $298K |
| Q1 2026 | $300K |
| Q1 2026 | $190K |
| Q2 2026 | $584K |
| Q2 2026 | $650K |
| Q3 2026 | $40K |
| Q3 2026 | $1.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $1.1M | 97.1K | — | — |
| Q3 2026 | $40K | 3.5K | — | — |
| Q2 2026 | $650K | 60.7K | — | — |
| Q2 2026 | $584K | 54.5K | — | — |
| Q1 2026 | $190K | 17.3K | — | — |
| Q1 2026 | $300K | 27.2K | — | — |
| Q1 2026 | $298K | 27.0K | — | — |
| Q1 2026 | $131K | 11.9K | — | — |
| Q4 2025 | $793K | 38.9K | — | — |
| Q4 2025 | $1K | 55 | — | — |
| Q4 2025 | $660K | 32.4K | — | — |
| Q4 2025 | $2.5M | 123.0K | — | — |
| Q3 2025 | $643K | 40.6K | — | — |
| Q3 2025 | $291K | 18.4K | — | — |
| Q3 2025 | $1M | 65.0K | — | — |
| Q3 2025 | $1.3M | 84.6K | — | — |
| Q3 2025 | $1.6M | 103.4K | — | — |